NDC Code(s) : 76296-014-40
Packager : Caudalie USA Inc.

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Caudalie Resveratrol Face Lifting Moisturizer Broad Spectrum SPF 20AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE CREAM
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:76296-014
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
AVOBENZONE(UNII: G63QQF2NOX)
(AVOBENZONE - UNII:G63QQF2NOX)
AVOBENZONE30 mg in 1 mL
OCTINOXATE(UNII: 4Y5P7MUD51)
(OCTINOXATE - UNII:4Y5P7MUD51)
OCTINOXATE40 mg in 1 mL
OCTISALATE(UNII: 4X49Y0596W)
(OCTISALATE - UNII:4X49Y0596W)
OCTISALATE50 mg in 1 mL
OCTOCRYLENE(UNII: 5A68WGF6WM)
(OCTOCRYLENE - UNII:5A68WGF6WM)
OCTOCRYLENE80 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER(UNII: 059QF0KO0R)
HEPTYL UNDECYLENATE(UNII: W77QUB6GXO)
DIMETHICONE(UNII: 92RU3N3Y1O)
DICAPRYLYL CARBONATE(UNII: 609A3V1SUA)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
SQUALANE(UNII: GW89575KF9)
GLYCERYL STEARATE CITRATE(UNII: WH8T92A065)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
GLYCERIN(UNII: PDC6A3C0OX)
POTASSIUM CETYL PHOSPHATE(UNII: 03KCY6P7UT)
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
MICA(UNII: V8A1AW0880)
.ALPHA.-TOCOPHEROL ACETATE(UNII: 9E8X80D2L0)
BENZYL ALCOHOL(UNII: LKG8494WBH)
CAPRYLYL GLYCOL(UNII: 00YIU5438U)
XANTHAN GUM(UNII: TTV12P4NEE)
SORBITAN MONOLAURATE(UNII: 6W9PS8B71J)
DEHYDROACETIC ACID(UNII: 2KAG279R6R)
ACETYL TYROSYLARGININE CETYL ESTER(UNII: 3M7W78X5IR)
HYALURONIC ACID(UNII: S270N0TRQY)
HEXASODIUM PHYTATE(UNII: ZBX50UG81V)
CITRIC ACID MONOHYDRATE(UNII: 2968PHW8QP)
STANNIC OXIDE(UNII: KM7N50LOS6)
TOCOPHEROL(UNII: R0ZB2556P8)
LINALOOL, (+/-)-(UNII: D81QY6I88E)
COUMARIN(UNII: A4VZ22K1WT)
BUTYLPHENYL METHYLPROPIONAL(UNII: T7540GJV69)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:76296-014-401 in 1 CARTON 29/07/2015
140 mL in 1 TUBE Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part352 07/29/2015 02/28/2018

PRINCIPAL DISPLAY PANEL

DrugFactsDrugFacts